E2F activity is biphasically regulated by androgens in LNCaP cells

被引:51
作者
Hofman, K [1 ]
Swinnen, JV [1 ]
Verhoeven, G [1 ]
Heyns, W [1 ]
机构
[1] Catholic Univ Louvain, Lab Expt Med & Endocrinol, B-3000 Louvain, Belgium
关键词
E2F; LNCaP; androgens; prostate cancer; proliferation; differentiation; retinoblastoma; p27(KIP1);
D O I
10.1006/bbrc.2001.4738
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgens exert a peculiar biphasic dose-dependent influence on the proliferation of LNCaP cells, a widely used model to study androgen effects on prostate cancer cells. Low concentrations of androgen stimulate proliferation, but high concentrations inhibit proliferation and induce strong expression of differentiation markers. In order to gain more insight into the molecular mechanisms that underlie these changes we studied the influence of a wide concentration range of the synthetic androgen R1881 on several cell cycle- and differentiation-related parameters. Low concentrations (0.1 nM), known to promote LNCaP cell proliferation, induce an increase of Retinoblastoma protein phosphorylation, accompanied by an increase of E2F-1 protein levels and E2F activity and by increased expression of the E2F-target gene products E2F-1 and cyclin A. High concentrations of R1881 (10 nM) induce strong expression of the differentiation marker prostate-specific antigen. Retinoblastoma protein is largely hypophosphorylated, resulting in low E2F activity and low concentrations of E2F-1 and cyclin A mRNA. Finally, there is a strong increase of p27(Kip1) protein, but not of p27(Kip1) mRNA. These results indicate that the biphasic dose response of LNCaP proliferation to androgen is closely reflected in Rb phosphorylation, E2F activity and p27(Kip1) protein expression. (C) 2001 Academic Press.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 28 条
  • [1] Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
    Agus, DB
    Cordon-Cardo, C
    Fox, W
    Drobnjak, M
    Koff, A
    Golde, DW
    Scher, HI
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) : 1869 - 1876
  • [2] Chen Y, 1996, CELL GROWTH DIFFER, V7, P1571
  • [3] Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
    Cordon-Cardo, C
    Koff, A
    Drobnjak, M
    Capodieci, P
    Osman, I
    Millard, SS
    Gaudin, PB
    Fazzari, M
    Zhang, ZF
    Massague, J
    Scher, HI
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (17): : 1284 - 1291
  • [4] Androgen receptor - an update of mechanisms of action in prostate cancer
    Culig, Z
    Hobisch, A
    Bartsch, G
    Klocker, H
    [J]. UROLOGICAL RESEARCH, 2000, 28 (04): : 211 - 219
  • [5] The regulation of E2F by pRB-family proteins
    Dyson, N
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2245 - 2262
  • [6] Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO
  • [7] 2-H
  • [8] E2F-1-MEDIATED TRANSACTIVATION IS INHIBITED BY COMPLEX-FORMATION WITH THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT
    FLEMINGTON, EK
    SPECK, SH
    KAELIN, WG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 6914 - 6918
  • [9] Fribourg AF, 2000, CELL GROWTH DIFFER, V11, P361
  • [10] Androgen receptor signalling in the prostate
    Gnanapragasam, VJ
    Robson, CN
    Leung, HY
    Neal, DE
    [J]. BJU INTERNATIONAL, 2000, 86 (09) : 1001 - 1013